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Abstract
Alkyl and aryl isothiocyanates and carbodiimides are effective substrates in (3 + 2) cycloadditions
with N–sulfonyl-2-substituted aziridines and 2-phenylaziridine for the synthesis of
iminothiazolidines and iminoimidazolidines. Additionally, the stereoselective (3 + 2)
cycloaddition of N–H- and N–sulfonylaziridines with isothiocyanates can be accomplished,
allowing for the synthesis of highly enantioenriched iminothiazolidines. Evidence for an intimate
ion-pair mechanism is presented herein in the context of these chemo-, regio-, and
diastereoselective transformations.The demonstrated ability to remove the sulfonyl group from the
heterocyclic products displays the utility of these compounds for further derivatization and
application.
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Introduction
Aziridines are versatile intermediates and reaction partners for the preparation of a
structurally diverse assortment of nitrogen-containing architectures.[1] These heterocycles
are characterized by a unique reactivity profile, in part due to the large strain energy (27 kcal
mol−1) contained within their 3-membered ring structure,[2] rendering them susceptible to
nucleophilic ring opening,[3] carbonylation,[4] and ring expansion.[5] Previous work has
shown the utility of 2-arylaziridines in transition metal-mediated and -catalyzed (3 + 2)
cycloadditions with heterocumulenes for the formation of imidazolines,[6a–e]
oxazolidines,[6d–e] iminoazolidinones,[6f–i] iminothiazolidines,[6i–k] and
iminoimidazolidines.[6f,i] Iminothiazolidines and iminoimidazolidines have enjoyed broad
application as effective organic catalysts in asymmetric transformations including Strecker
reactions,[7a] O− and N–acylations,[7b–c] and Michael additions,[7d] and as highly active
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pharmacophores for treatment of a wide range of medical conditions including obesity,
diabetes, cancer, and arthritis.[8]
The critical limitation of the majority of the existing (3 + 2) cycloaddition manifolds is the
requirement that aziridine starting materials bear either alkyl or aryl N–substitution. The
harsh conditions necessary for the removal of such robust groups severely limits the
potential for derivatization and, thus, the utility of the products. Despite this, the use of N–
sulfonyl protected aziridines in (3 + 2) cycloadditions has been explored minimally.[6a–e,k]
In fact, only the work of Nadir and co-workers has examined the (3 + 2) cycloadditions of
N–sulfonyl-2-arylaziridines with heterocumulenes.[6k,9] Their reaction system has a arrow
scope and is only able to accommodate aryl isocyanates and aryl isothiocyanates, resulting
in similarly limited product derivatization options. This transformation depends on the use
of alkali metal iodides as a noninnocent reaction partner; Nadir and co-workers explicitly
demonstrated the formation of the ring-opened iodide intermediate prior to product
formation.
Additionally, only a single example is known for the synthesis of enantioenriched
iminothiazolidines via a stereoselective (3 + 2) cycloaddition[6i] despite readily available
enantioenriched aziridine starting materials.[1,2,6h] This method, however, has an extremely
narrow substrate scope, requiring the use of N–alkyl- or N–arylaziridines and aryl
heterocumulenes. There are no examples of this transformation with N–sulfonyl protected
aziridines or more synthetically versatile heterocumulenes.
From this foundation, we sought to develop the first stereoselective Lewis acid mediated (3
+ 2) cycloaddition reaction of N–sulfonyl-2-substituted aziridines and alkyl
heterocumulenes. The Lewis acid mediated conditions would likely enable the use of a
broad variety of heterocumulenes and consequently furnish readily derivatizable, highly
enantioenriched heterocyclic building blocks.
Results and Discussion
Optimization of Reaction Conditions
Initial reaction development focused on the cycloaddition of N–tosyl-2-phenylaziridine (1a)
with allyl isothiocyanate (Table 1). In contrast to our previous work on (3 + 2)
cycloadditions of donor–acceptor cyclopropanes with heterocumulenes,[10] tin(II) triflate
was found to be an ineffective Lewis acid mediator for the desired transformation (entry 1).
Alternatively, zinc(II) salts proved competent for the formation of iminothiazolidine 2a.
While zinc(II) triflate furnished the product in good yield, the reaction times were greatly
reduced when zinc(II) halides were employed (entries 2–5). Lithium bromide mediated
reaction conditions resulted in low conversion (entry 6). Attempts to develop a catalytic
system with zinc(II) bromide proved unsuccessful, even in the presence of additional
bromide ion (entry 7). Ultimately, the use of 1.25 equivalents of zinc(II) bromide and 2.00
equivalents of allyl isothiocyanate in dichloromethane at ambient temperature proved
optimal. (entry 5).[11]
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Exploration of 2-Aziridine and Heterocumulene Substitution
With optimal conditions identified, we examined the substrate scope of the reaction. We
found that a variety of N–tosyl-2-arylsubstituted aziridines participated effectively in the
zinc(II) bromide mediated (3 + 2) cycloaddition with allyl isothiocyanate to yield the
corresponding iminothiazolidine products with complete chemo- and regioselectivity
(Scheme 1).[12,13] Altering the C–aryl substitution from phenyl to mesityl allowed for the
formation of the corresponding heterocycle (2b) in shorter reaction time despite the
increased steric bulk.[14] Similarly, (p-tolyl)thiazolidine 2c was successfully furnished with
a slightly decreased yield. Acetoxy substitution was compatible with the reaction conditions
as well, generating 2d in excellent yield. Compared to the p-chlorophenyl- or o-
chlorophenylthiazolidines (2e and 2g, respectively), the more electronically deactivated m-
chlorophenylthiazolidine 2h was produced more slowly, albeit without any significant
reduction in yield.[15] The highly electron-deficient p-nitrophenylthiazolidine 2f was formed
in modest yield, with a significant portion of starting material lost to nucleophilic ring
opening of the aziridine by the bromide counterion.[16] Substrates bearing coordinating C–
aryl substituents served to slow the rate of reaction (e.g., 2d,2f) or require additional ZnBr2
to drive the reaction to completion (2i). Styrenyl thiazolidine 2j could also be synthesized in
approximately the same reaction time as phenyl product 2a. Additionally, primary and
secondary alkyl isothiocyanates were found to be highly compatible under the reaction
conditions as were electron-neutral, -rich, and -deficient aryl isothiocyanates, all furnishing
the desired iminothiazolidines in excellent yields (2k, 2l, 2m, 2n, and 2o, respectively).
In contrast to the C–aryl-substituted aziridines, C–alkyl-substituted aziridine 4 reacted with
allyl isothiocyanate under the reaction conditions to furnish two isomeric (3 + 2) adducts
(Scheme 2). Formation of 5-alkyl-substituted iminothiazolidine 5 was accomplished in only
18% yield, while 4-alkyl-substituted product 6 was furnished in 56% yield. While C–alkyl-
substituted aziridines are suitable reaction partners in the (3 + 2) cycloaddition and the
heterocyclic products are formed with complete chemoselectivity, they are not formed with
the regiofidelity exhibited by aziridines substituted at carbon with aryl groups or other
conjugated systems.
Effects of Aziridine N–Substitution
As an extension of the substrate scope, we investigated the effect of N–substitution on the
aziridine (Table 2). Aziridines protected with N–sulfonyl groups provided the desired
iminothiazolidines (2a, 8a–8c) in excellent yields, generally showing reaction times that
were slightly shorter for electron-deficient sulfonyl groups (entry 2) and slightly longer for
more electron-rich sulfonyl groups (entries 3–4) in comparison to the N–tosyl-substituted
substrate (entry 1). Interestingly, unprotected 2-phenylaziridine showed an improved
reaction time yet a partially decreased yield of the heterocyclic product 8d while N–(n-
decyl)-substituted aziridine was unreactive under the reaction conditions (entries 5–6). N–
Acyl aziridines also failed to furnish any of the desired heterocycles 8f and 8g (entries 7–8).
Craig et al. Page 3
Chemistry. Author manuscript; available in PMC 2015 April 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Extension of Heterocumulene Scope
Subsequently, we turned our attention to broadening the scope of competent
heterocumulenes and found that while isocyanates gave only trace yields of the (3 + 2)
cycloaddition adducts,[17] carbodiimides were compatible with the conditions, furnishing a
variety of iminoimidazolidines (Scheme 3).[18] Our unique zinc-mediated conditions
enabled the (3 + 2) cycloadditions of N–sulfonyl aziridines with dialkyl- and disilyl-
carbodiimides, unlike any previously published systems,[6,9] furnishing
diisopropyliminoimidazolidine 9a and secondary imidazolidine 9b. In accordance with our
observations in the isothiocyanate (3 + 2) cycloadditions, a variety of 2-arylaziridines were
suitable reaction partners with diphenylcarbodiimide (9c–9e).
Cycloaddition of Disubstituted N–Sulfonylaziridines
During our investigation of the substrate scope of the (3 + 2) cycloaddition of N–
sulfonylaziridines with isothiocyanates, we discovered that trans-2,3-disubstituted aziridine
10 was an acceptable reaction partner, furnishing cis-thiazolidine 11 in high yield in the
shortest reaction time observed for any N–tosyl-substituted substrate (Scheme 4).
Iminothiazolidine 11 was formed as a single diastereomer, and the relative stereochemistry
was confirmed by single crystal X-ray diffraction. The cis configuration of product 11 led to
the hypothesis that the mechanism of the reaction involves inversion at the benzylic position
of the aziridine starting material.[19]
In order to confirm the chemo-, regio-, and diastereoselective formation of cis-thiazolidine
11 was non-substrate dependent, we exposed trans-2,3-disubstituted acroylaziridine 12 to
identical reaction conditions and were pleased to find that cis-acroylthiazolidine 13 was
similarly formed as the sole product and a single diastereomer (Scheme 5).
Contrastingly, the (3 + 2) cycloaddition of allyl isothiocyanate with cis-2,3-disubstituted
aziridine 15 resulted in the non-diastereoselective formation of both trans-thiazolidine 16
and the cis isomer 17 (Scheme 6a). Interestingly, exposure of cis-aziridine 15 to the reaction
conditions in the absence of heterocumulene resulted in the rapid formation of pyrrolines 18
and 19 (Scheme 6b).[20] Finally, we found that geminally disubstituted N–tosyl-2-methyl-2-
phenylaziridine failed to provide any (3 + 2) cycloaddition product.[21]
Stereoselective (3 + 2) Cycloaddition
The formation of cis-thiazolidines 11 and 13 with excellent chemo-, regio-, and
diastereoselectivity intimated the potential to develop a stereoselective reaction manifold.
Initial development focused on the (3 + 2) cycloaddition of (R)-N–tosyl-2-phenylaziridine
((R)-1a) with allyl isothiocyanate (Table 3).[22] The optimized zinc(II) bromide mediated
reaction conditions furnished (S)-2a in excellent yield and 42% ee (entry 1). Other zinc(II)
halide salts furnished the desired product in similar yield with increased ee when zinc(II)
chloride was employed (entries 2–3). Zinc(II) triflate provided no improvement in the ee of
(S)-2a (entry 4). Lithium bromide mediated and catalytic zinc(II) bromide conditions both
exhibited incomplete conversion of (R)-1a (entries 5–6). Interestingly, while the lithium
bromide conditions furnished the opposite enantiomer (R)-2a, the catalytic zinc(II) bromide
conditions produced (S)-2a in an improved 69% ee. Inspired by this result, we were pleased
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to find that increasing the equivalents of isothiocyanate in the presence of stoichiometric
zinc(II) bromide could provide a similar boost in ee while maintaining full conversion of the
starting material (entry 7). Ultimately, the use of 1.25 equivalents of zinc(II) chloride and
10.00 equivalents of allyl isothiocyanate in dichloromethane at ambient temperature proved
optimal, furnishing (S)-2a in 99% yield and 94% ee (entry 8).
Exploration of Isothiocyanate Substitution
With optimal conditions identified, we examined the scope of heterocumulene substitution
in the reaction.[23] We found that, along with allyl isothiocyanate, primary and secondary
alkyl isothiocyanates were all highly compatible under the reaction conditions, furnishing
desired enantioenriched iminothiazolidines (S)-2a, (S)-2k, and (S)-2l in uniformly excellent
yields and ee (Scheme 7).[13] The use of a tertiary isothiocyanate, however, extended the
reaction time and provided thiazolidine (S)-2p in decreased yield and ee. Additionally, aryl
isothiocyanates were competent cycloaddition reaction partners under the zinc(II) chloride
mediated conditions, providing thiazolidine products (S)-2m, (S)-2n, and (S)-2o in excellent
yields. While phenyliminothiazolidine (S)-2m was isolated with good ee, the use of a more
electron-rich isothiocyanate resulted in the formation of a thiazolidine product ((S)-2n) with
an excellent 90% ee while the use of a more electron-deficient isothiocyanate provide a
product with a significantly lower ee ((S)-2o).
Effects of Aziridine N–Substitution on the Transfer of Chiral Information
We subsequently investigated the effect of N–substitution on the aziridine in the
stereoselective (3 + 2) cycloaddition. Aziridines with N–sulfonyl substitutions were
extremely well tolerated under the reaction conditions, furnishing the desired thiazolidines
((S)-2a, (S)-8a–(S)-8c) in excellent yield with uniformly high ee’s, exhibiting reaction times
that increased slightly moving from more electron-deficient (entry 2) to more electron-rich
(entry 4) sulfonyl groups (Table 4). While the N–H aziridine showed an improved reaction
time, unfortunately both the yield and ee of thiazolidine (S)-8d were reduced (entry 5).
Proposed Mechanism of Stereoselective(3 + 2) Cycloaddition
We hypothesize that the mechanism of the (3 + 2) cycloadditions presented herein proceed
through a stereoselective intimate-ion pair mechanism similar to that invoked in our
previous work[10] and by Johnson[24] and Kerr[25] in related work on the cycloadditions of
donor–acceptor cyclopropanes (Scheme 8). Our observations including lack of reactivity in
the absence of Lewis acid,[11,26] inversion at the benzylic position, greater reactivity of
aziridines with electron-rich aryl substituents, and shorter reaction times of N-substituted
aziridines with more electron-withdrawing groups are all consistent with this mechanistic
hypothesis. The formation of (R)-2a under lithium bromide mediated conditions strongly
suggests we have developed a Lewis acid mediated process in contrast to the related alkali
metal iodide mediated system reported by Nadir and co-workers,[6k,9] who observe overall
stereoretention as a result of a double inversion pathway, which proceeds through a
halogenated intermediate, and the palladium(II)-catalyzed reaction conditions of Alper and
co-workers[6i] who also observe the stereoretentive product as the major enantiomer. This
hypothesis also accounts for the observed nondiastereoselective formation of thiazolidines
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16 and 17 and pyrrolines 18 and 19, considering the fully separated ion pair intermediate
that likely results from destabilization of the polarizing C–N bond by the steric interaction
between the cis substituents on aziridine 15 (see Scheme 6).
Cycloaddition of a Diester Aziridine
Noting the apparent mechanistic similarities with our previous work,[10] we synthesized
diester aziridine 22 to assess the potential for selective activation of the C–C or C–N bond
under either our tin(II) or zinc(II) mediated conditions, respectively.[27] Unfortunately,
Sn(OTf)2 failed to provide any cycloaddition product.[28] Alternatively, use of ZnBr2
provided thiolactam 23 as the sole (3 + 2) adduct (Scheme 9a). This is the only thiolactam (3
+ 2) cycloaddition product observed during our studies.[13] The ability of the malonate
group to stabilize the negative charge and the nitrogen to further stabilize the benzylic
positive charge allows for the formation of zwitterionic 24, likely resulting in the observed
divergent reactivity (Scheme 9b).[29]
Deprotection of N–Sulfonyl Heterocycles
Having explored a range of substrates, heterocumulenes, and N–protecting groups, we next
sought to assess the potential to derivatize our heterocyclic products. As expected, the N–
sulfonyl protecting group removal was trivial. Secondary iminothiazolidine (S)-8d could be
accessed rapidly in an excellent 91% yield without any loss of enantiomeric excess through
detosylation of thiazolidine (S)-2a (Scheme 10a)[30] or through the desulfonylation of p-
nosyl-protected thiazolidine (S)-8a with slightly increased yield (Scheme 10b), furnishing
thiazolidine (S)-8d in 87% yield and 94%ee over two steps from (R)-N–(p-
nitrobenzenesulfonyl)-2-phenylaziridine.[31]
Alternatively, cleavage of the allyl imine C–N bond of heterocycle (S)-2a in the presence of
palladium(0) enabled access to secondary iminothiazolidine (S)-25 with some loss of
enantiomeric excess (Scheme 10c). While the cleavage of N–allyl bonds has been shown in
the literature for functional groups including amines[32] and amides,[33] this is the first
known example of the cleavage of an imino N–allyl bond.
Iminothiazolidines (S)-8d and (S)-25 are extremely versatile heterocycles. Derivatization
and synthetic manipulations of the imine, allyl group, and secondary nitrogen could be
envisioned to provide rapid access to highly enantioenriched oxothiazolidines, thiazoles, and
a variety of polyclic scaffolds.[34] Critically, access to the enantioenriched secondary
thiazolidine and imidazolidine products enabled by our (3 + 2) cycloaddition allows for their
use as asymmetric organic catalysts, as the free secondary nitrogen functions as a necessary
hydrogen bond donor for the majority of these applications.[7a–d]
Conclusion
We have disclosed the first stereoselective Lewis acid mediated (3 + 2) cycloaddition of N–
H- and N–sulfonylaziridines with alkyl heterocumulenes. These zinc(II) mediated conditions
offer broad tolerance of alkyl, silyl, and aryl heterocumulenes, as well as aziridine
substitution, enabling the formation of iminoimidazolidines and enantioenriched
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iminothiazolidines in overall excellent yields from enantioenriched aziridines, which are
easily accessible from their amino acid precursors. Combined with the exhibited ability to
simply remove the sulfonyl and allyl protecting groups, this reaction system enables the
installation of a broad number of functional group handles for further derivatization of these
biologically and catalytically important heterocyclic scaffolds.
Experimental Section
Representative General Procedure for the (3 + 2) Cycloaddition of N–H- and N–
Sulfonylaziridines with Heterocumulenes
To an oven-dried 1-dram vial equipped with a magnetic stir bar was added zinc(II) bromide
(113 mg, 0.50 mmol, 1.25 equiv), freshly powdered with a mortar and pestle, in an inert
atmosphere glovebox. The vial was sealed with a screw cap fitted with a Teflon septum,
removed from the glovebox, and placed under an inert atmosphere. To a separate, oven-
dried 1-dram vial was added N–tosyl-2-phenylaziridine (1a, 109 mg, 0.40 mmol, 1.00
equiv). The vial was then sealed with a screw cap fitted with a Teflon septum and anhydrous
CH2Cl2 (0.60 mL) and allyl isothiocyanate (79 μl, 0.80 mmol, 2.00 equiv) were added. The
mixture was transferred to the first vial with a rinse of anhydrous CH2Cl2 (0.20 mL). The
heterogeneous reaction mixture was then allowed to stir at ambient temperature. Upon
consumption of the aziridine (determined by TLC), the reaction solution was diluted with
CH2Cl2 (3 mL) and CH3OH (1 mL), adsorbed onto Celite, and purified by silica gel column
chromatography (20% acetone in hexanes eluent) to furnish thiazolidine 2a (147 mg, 99%
yield) as an amorphous white solid.
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Scheme 1.
Substrate Scope of Isothiocyanate (3 + 2) Cycloaddition[a]
[a] Conditions: aziridine 1 (0.40 mmol), isothiocyanate (0.80 mmol), ZnBr2 (0.50 mmol),
CH2Cl2 (0.80 mL). [b] Isolated yield. [c] The product of nucleophilic ring opening of the
starting material by bromide ion was isolated in 35% yield. [d] 0.90 mmol of ZnBr2.
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Scheme 2.
(3 + 2) Cycloaddition with 2-Alkylaziridine 4
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Scheme 3.
Substrate Scope of Carbodiimide (3 + 2) Cycloaddition[a]
[a] Conditions: aziridine 1 (0.40 mmol), carbodiimide (0.41 mmol), ZnBr2 (0.50 mmol),
CH2Cl2 (0.80 mL). [b] Isolated yield. [c] Bis(trimethylsilyl)carbodiimide was used.
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Scheme 4.
Diastereoselective (3 + 2) Cycloaddition with Aziridine 10
Craig et al. Page 13
Chemistry. Author manuscript; available in PMC 2015 April 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 5.
Diastereoselective (3 + 2) Cycloaddition with Aziridine 12
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Scheme 6.
(3 + 2) Cycloaddition with Aziridine 15
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Scheme 7.
Substrate Scope of Stereoselective Isothiocyanate (3 + 2) Cycloaddition [a]
[a] Conditions: aziridine (R)-1 (0.40 mmol, 99% ee), isothiocyanate (4.00 mmol), ZnCl2
(0.50 mmol), CH2Cl2 (0.80 mL). [b] Isolated yields. [c] Determined by analytical chiral
SFC.
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Scheme 8.
Proposed General Mechanism for Stereoselective (3 + 2) Cycloaddition
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Scheme 9.
(3 + 2) Cycloaddition with Diesteraziridine 22
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Scheme 10.
Desulfonylation and Deallylation of Iminothiazolidine Products
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Table 1
Optimization of Reaction Conditions[a]
entry Lewis acid time (h) yield (%)[b]
1 Sn(OTf)2 1.0 0
2 Zn(OTf)2 60.0 79
3 ZnCl2 6.0 95
4 ZnI2 3.0 95
5 ZnBr2 1.3 99
6 LiBr2[c] 72.0[d] 7
7 ZnBr2[e] 72.0[d] 4
[a]Conditions: aziridine 1a (0.40 mmol), isothiocyanate (0.80 mmol), Lewis acid (0.50 mmol), CH2Cl2 (0.80 mL).
[b]
Isolated yield.
[c]1.00 mmol of LiBr.
[d]Starting material was not fully consumed.
[e]0.12 mmol of ZnBr2 with 0.40 mmol of tetra(n-butyl)ammonium bromide. Ts = p-CH3-C6H4-SO2, Tf = F3C-SO2
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Table 2
N-Substitution Scope of Isothiocyanate (3 + 2) Cycloaddition[a]
entry R product time(h) yield (%)[b]
1 tosyl 2a 1.3 99
2 p-NO2-C6H4-SO2 8a 1.2 94
3 mesyl 8b 1.8 91
4 p-OMe-C6H4-SO2 8c 2.0 90
5 H 8d 0.5 75
6 n-C10H21 8e 96.0[c] 0
7 pivaloyl 8f 96.0[c] 0
8 benzoyl 8g 96.0[c] 0
[a]Conditions: aziridine 7 (0.40 mmol), isothiocyanate (0.80 mmol), ZnBr2 (0.50 mmol), CH2Cl2 (0.80 mL).
[b]
Isolated yield.
[c]Starting material was not consumed.
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Table 3
Optimization of Stereoselective Reaction Conditions[a]
entry Lewis acid time (h) yield (%)[b] ee (%)[c]
1 ZnBr2 1.3 99 42
2 Znl2 3.0 95 32
3 ZnCl2 6.0 95 63
4 Zn(OTf)2 60.0 79 31
5 LiBr 96[d] 10 −76
6 ZnBr2[e] 72[d] 67 69
7 ZnBr2[f] 1.3 98 65
8 ZnCI2[g] 2.0 99 94
[a]Conditions: aziridine (R)-1a (0.40 mmol, 99% ee), isothiocyanate (0.80 mmol), Lewis acid (0.50 mmol), CH2Cl2 (0.80 mL).
[b]
Isolated yield.
[c]
Determined by analytical chiral SFC.
[d]Starting material was not fully consumed.
[e]0.12 mmol of ZnBr2.
[f]6.00 equiv allyl isothiocyanate.
[g]10.00 equiv allyl isothiocyanate.
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